Development and Application of Assisted Reproductive Technologies in Marsupials: Their Value for Conservation of Rock-wallabies.

1996 ◽  
Vol 19 (2) ◽  
pp. 183
Author(s):  
D.A. Taggart ◽  
D. Schultz ◽  
P.D. Temple-Smith
Keyword(s):  
Genetic Variability ◽  
Wildlife Conservation ◽  
Reproductive Output ◽  
Assisted Reproductive Technologies ◽  
Reproductive Technologies ◽  
Reproductive Technology ◽  
Domestic Species ◽  
Reproductive Techniques ◽  
Marsupial Species ◽  
Insight Into

Assisted reproductive technology is used routinely in management to treat infertility and in domestic species in basic husbandry. In eutherian mammals application of this technology is also well established in wildlife conservation programs. The development and application of this technology in marsupials, however, is a relatively new field. The reproductive techniques currently available for marsupial studies, their benefits and implications for conservation are discussed in order to remove any previous misconceptions and provide an insight into how these techniques might be applied. The potential of this technology for maintaining genetic variability and enhancing reproductive output of threatened marsupial species is highlighted, with particular reference to the conservation of rock wallabies.

scholarly journals Does the Human Assisted Reproductive Technology Act 2004 need a review?

2021 ◽  
Vol 17 (1) ◽  
Author(s):  
Michael Legge ◽  
Ruth Fitzgerald
Keyword(s):  
New Zealand ◽  
Assisted Reproductive Technology ◽  
Assisted Reproductive Technologies ◽  
Reproductive Technologies ◽  
Reproductive Technology ◽  
Good Coverage

The use of assisted reproductive technologies (ART) in New Zealand is governed by the Human Assisted Reproductive Technology Act 2004 (the HART Act), which provides for all procedures currently undertaken by fertility clinics and other centres involved with ART. Although the Act has provided good coverage for the use of ART over the last 16 years, it did not have a revision clause. Here, we explore whether the HART Act should be reviewed, and outline the important considerations that need to be taken into account to ensure that the legislation is up to date with current issues and technologies.

The Birth of Assisted Reproductive Technology in China

Good Quality ◽  
2018 ◽  
Author(s):  
Ayo Wahlberg
Keyword(s):  
Family Planning ◽  
Assisted Reproductive Technology ◽  
Birth Control ◽  
Assisted Reproductive Technologies ◽  
Reproductive Technologies ◽  
Reproductive Technology ◽  
The Core ◽  
Sperm Banks ◽  
Population Quality

This chapter chronicles the difficult birth of assisted reproductive technologies (ARTs) in China through the 1980s and 1990s, showing how ideas of improving population quality acted as a persuasive alibi for those pioneers working to develop fertility technologies under crude conditions and at a time when contraception rather than conception was at the core of family planning. From difficult beginnings in the 1980s and following legalization in 2003, ARTs have now settled firmly within China’s restrictive reproductive complex as technologies of birth control—which, in turn, has allowed it to grow into a thriving, sector as China is now home to some of the world’s largest fertility clinics and sperm banks.

Assisted Reproductive Technology in Spain: Considering Women's Interests

2009 ◽  
Vol 18 (3) ◽  
pp. 228-235 ◽  
Author(s):  
INMACULADA DE MELO-MARTÍN
Keyword(s):  
Assisted Reproductive Technology ◽  
Assisted Reproductive Technologies ◽  
Reproductive Technologies ◽  
Reproductive Technology ◽  
Assisted Conception ◽  
National Healthcare ◽  
The World ◽  
National Healthcare System ◽  
The Subject ◽  
Catholic Tradition

It might come as a surprise to many that Spain, a country with a strong Catholic tradition that officially banned contraceptive technologies until 1978, has some of the most liberal regulations in assisted reproduction in the world. Law No. 35/1988 was one of the first and most detailed acts of legislation undertaken on the subject of assisted-conception procedures. Indeed, not only did the law permit research on nonviable embryos, it made assisted reproductive technologies available to any woman, whether married or not, through the national healthcare system.

scholarly journals Assisted Reproductive Technologies for Women with Polycystic Ovarian Syndrome

2021 ◽  
Vol 14 (3) ◽  
pp. 1305-1308
Author(s):  
Muhjah Falah Hassan ◽  
Pallav Sengupta ◽  
Sulagna Dutta
Keyword(s):  
Polycystic Ovarian Syndrome ◽  
Assisted Reproductive Technologies ◽  
Polycystic Ovary ◽  
Fetal Loss ◽  
Reproductive Technologies ◽  
Fertilization Rate ◽  
Reproductive Age ◽  
Treatment Modalities ◽  
Reproductive Techniques ◽  
Ovarian Syndrome

Polycystic ovarian syndrome (PCOS) is the most common cause of anovulatory fertility problems in women of reproductive age, with a prevalence as high as 40% to 75%. There are different treatment modalities for increasing the chance of pregnancy in PCOS patients. Since most of the PCOS patients suffer from ovulatory problems, therapeutic efforts are focused mainly towards restoring normal ovulation. However, even after pharmacological interventions to ameliorate ovulatory irregularities, women with polycystic ovary are still at high risk of fetal loss. Thus, assisted reproductive techniques (ARTs) have become popular approaches which significantly increase the chances of successful pregnancy in these women, bypassing the conditions of PCOS. The present mini-review ‘pinpoints’ on the suitability of ARTs for PCOS patients who fail to ovulate following the conventional infertility treatment. The article also briefly explains how intracytoplasmic sperm injection (ICSI), the most effectiveART, correlates with better biological parameters, fertilization rate and better quality of embryos in PCOS women.

Trends in safe infertility treatment with assisted reproductive technologies

2020 ◽  
Vol 69 (4) ◽  
pp. 83-88
Author(s):  
Svetlana S. Paskar ◽  
Alla S. Kalugina ◽  
Anna G. Tkachuk
Keyword(s):  
Clinical Practice ◽  
Assisted Reproductive Technology ◽  
Assisted Reproductive Technologies ◽  
Perinatal Outcomes ◽  
Reproductive Technologies ◽  
Infertility Treatment ◽  
Reproductive Technology ◽  
Correct Prediction ◽  
Vitro Fertilization

The expansion of indications for assisted reproductive technology has led to significant implications for assisted reproductive technology (ART) programs worldwide. More than 7 million children in the world were born using ART. Modern clinical practice in the field of reproductive sciences is aimed not only at increasing the effectiveness, but also at the safety of treatment. ART, like any other type of therapy, may be combined with negative side effects. Both the correct prediction of the risks associated with treatment and a personalized approach ensure the absolute safety of infertility treatment using in vitro fertilization. In this regard, over the past decade, a number of new research approaches have been noted that use ART methods integrated into clinical practice: cycle segmentation with subsequent embryo transfer and the elective transfer of one embryo. New approaches provide a control in relation to ovarian stimulation and a reduction in the number of transferred embryos, which helps to minimize primarily adverse perinatal outcomes. Predicting the risks and outcomes of treatment using mathematical modeling is the application of good clinical practice.

Sign in / Sign up

Export Citation Format

Share Document